Skip to main content
Rural Health Information Hub

AstraZeneca Quality Improvement Grant for Lung Cancer

Sponsors
ASCO Foundation/Conquer Cancer, AstraZeneca
Deadlines
Jul 24, 2026
Contact

Andrew L. Smith, PhD
andrew.smith@conquer.org

Lynn Kayali, PharmD
lynn.kayali@astrazeneca.com

Ilker Arslan, MD
Ilker.Arslan@astrazeneca.com

Purpose

This opportunity offers funding to develop and deliver strategies to improve guideline concordant care (evidence-based clinical care) and/or clinical trial access for lung cancer patients in the community and rural care settings.

The goal of the program is to implement scalable, community-focused models that:

  • Increase adherence to guideline-recommended testing and treatments
  • Expand equitable clinical trial access and enrollment

Projects of interest include, but are not limited to:

  • Leveraging technology, including electronic health records and artificial intelligence, to improve adherence to testing and treatment recommendations, and identify potential clinical trial participants
  • Establish or enhance multi-disciplinary team approaches to ensure patients receive comprehensive and timely care across the disease continuum
  • Patient-centered approaches to help patients adhere to care guidelines, understand their options regarding clinical trials, and engage in shared decision making with their providers
  • Implementation of decentralized clinical trial models to promote access beyond traditional research hubs
Eligibility

Eligibility requirements:

  • Principal Investigators must be an oncologist with at least 5 years of experience.
  • The investigator and/or organization must ensure that lung cancer patients make up at least 15-20% of their patient population
  • Eligible organizations include community clinics, academic institutions, healthcare systems, hospitals, and other cancer care delivery organizations in the United States.
  • Only organizations are eligible to receive grants, not individuals or private practices.
  • Cross-organizational collaboration is encouraged, provided the project targets eligible community or rural populations.
  • The principal investigator must be an employee or contractor of the applicant organization.
Geographic coverage
Nationwide
Amount of funding

Award ceiling: $480,000
Project period: 24 months
Estimated total program funding: $480,000

Application process

Links to additional guidance, application instructions, and the online application portal are available on the program website.

Tagged as
Access · Cancer · Health information technology · Research methods and resources · Specialty care · Technology for health and human services



For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.